NO137997C - Analogifremgangsmaate til fremstilling av nye terapeutiske aktive sulfobenzosyreimidosubstituerte laktamer - Google Patents

Analogifremgangsmaate til fremstilling av nye terapeutiske aktive sulfobenzosyreimidosubstituerte laktamer

Info

Publication number
NO137997C
NO137997C NO669/73A NO66973A NO137997C NO 137997 C NO137997 C NO 137997C NO 669/73 A NO669/73 A NO 669/73A NO 66973 A NO66973 A NO 66973A NO 137997 C NO137997 C NO 137997C
Authority
NO
Norway
Prior art keywords
sulfobenzo
rimido
analogical
procedures
preparation
Prior art date
Application number
NO669/73A
Other languages
English (en)
Other versions
NO137997B (no
Inventor
Ivars Graudums
Heinrich Mueckter
Ernst Frankus
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19722210166 external-priority patent/DE2210166C3/de
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of NO137997B publication Critical patent/NO137997B/no
Publication of NO137997C publication Critical patent/NO137997C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO669/73A 1972-03-03 1973-02-19 Analogifremgangsmaate til fremstilling av nye terapeutiske aktive sulfobenzosyreimidosubstituerte laktamer NO137997C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722210166 DE2210166C3 (de) 1972-03-03 3-(o-Sulfobenzoesäureimido)-piperidone und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
NO137997B NO137997B (no) 1978-02-27
NO137997C true NO137997C (no) 1978-06-07

Family

ID=5837737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO669/73A NO137997C (no) 1972-03-03 1973-02-19 Analogifremgangsmaate til fremstilling av nye terapeutiske aktive sulfobenzosyreimidosubstituerte laktamer

Country Status (29)

Country Link
US (1) US3951985A (no)
JP (3) JPS5120510B2 (no)
AR (3) AR205791A1 (no)
AT (2) AT323189B (no)
AU (1) AU467882B2 (no)
BE (1) BE796167A (no)
CA (1) CA982586A (no)
CH (3) CH581652A5 (no)
CS (3) CS183678B2 (no)
DD (1) DD105804A5 (no)
DK (1) DK141530C (no)
ES (1) ES412220A1 (no)
FI (1) FI56008C (no)
FR (1) FR2174924B1 (no)
GB (1) GB1377896A (no)
HK (1) HK55678A (no)
HU (1) HU164901B (no)
IE (1) IE37298B1 (no)
IL (1) IL41391A (no)
MY (1) MY7800168A (no)
NL (1) NL178077C (no)
NO (1) NO137997C (no)
PH (1) PH10714A (no)
PL (3) PL94078B1 (no)
RO (3) RO66793A (no)
SE (1) SE387121B (no)
SU (3) SU502607A3 (no)
YU (3) YU35887B (no)
ZA (1) ZA73468B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048663A1 (de) * 1980-12-23 1982-07-22 Grünenthal GmbH, 5190 Stolberg Neue lactamverbindungen, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel
JPS6065903A (ja) * 1984-07-31 1985-04-15 株式会社日立製作所 軸支持装置
US5443824A (en) * 1994-03-14 1995-08-22 Piacquadio; Daniel J. Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
US7022844B2 (en) 2002-09-21 2006-04-04 Honeywell International Inc. Amide-based compounds, production, recovery, purification and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314960A (en) * 1964-08-25 1967-04-18 American Home Prod Benzisothiazol glutarimides

Also Published As

Publication number Publication date
FI56008C (fi) 1979-11-12
RO66743A (ro) 1981-03-30
JPS5120510B2 (no) 1976-06-25
YU35887B (en) 1981-08-31
JPS48103572A (no) 1973-12-25
YU35596B (en) 1981-04-30
RO66793A (ro) 1980-06-15
MY7800168A (en) 1978-12-31
SU566521A3 (ru) 1977-07-25
DK141530C (da) 1980-10-06
YU38973A (en) 1981-02-28
NL178077C (nl) 1986-01-16
IL41391A (en) 1975-10-15
IL41391A0 (en) 1973-03-30
PL94473B1 (pl) 1977-08-31
PL94078B1 (en) 1977-07-30
AT323189B (de) 1975-06-25
CH581652A5 (no) 1976-11-15
AU467882B2 (en) 1975-12-18
FI56008B (fi) 1979-07-31
CA982586A (en) 1976-01-27
JPS5234625B2 (no) 1977-09-05
AR196910A1 (es) 1974-02-28
HU164901B (no) 1974-05-28
PL94080B1 (en) 1977-07-30
AU5182873A (en) 1974-08-08
CH590861A5 (no) 1977-08-31
BE796167A (fr) 1973-09-03
AT327213B (de) 1976-01-26
DD105804A5 (no) 1974-05-12
IE37298B1 (en) 1977-06-22
DK141530B (da) 1980-04-14
ZA73468B (en) 1973-10-31
RO66064A (fr) 1979-07-15
HK55678A (en) 1978-09-29
NL7301783A (no) 1973-09-06
AR206786A1 (es) 1976-08-23
NO137997B (no) 1978-02-27
ATA734874A (de) 1975-04-15
AR205791A1 (es) 1976-06-07
YU208379A (en) 1980-10-31
CS183695B2 (en) 1978-07-31
US3951985A (en) 1976-04-20
IE37298L (en) 1973-09-03
SE387121B (sv) 1976-08-30
FR2174924A1 (no) 1973-10-19
GB1377896A (en) 1974-12-18
PH10714A (en) 1977-08-25
JPS51125077A (en) 1976-11-01
SU502607A3 (ru) 1976-02-05
ES412220A1 (es) 1976-01-01
CH583733A5 (no) 1977-01-14
JPS51125076A (en) 1976-11-01
CS183678B2 (en) 1978-07-31
JPS5234626B2 (no) 1977-09-05
SU540571A3 (ru) 1976-12-25
YU208479A (en) 1980-10-31
FR2174924B1 (no) 1976-12-03
CS183694B2 (en) 1978-07-31
YU35595B (en) 1981-04-30

Similar Documents

Publication Publication Date Title
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO140854C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptid-amider
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO138374C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-fenoksyfenoksyalkankarboksylsyrederivater
NO145241C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme o-substituerte 7beta-acylamino-3-cefem-3-ol-4-karboksylsyre-forbindelser
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO137782C (no) Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO136360C (no) Analogifremgangsm}te for fremstilling av nye terapeutisk aktive 2-fenylamino-imidazolin-(2)-er
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO138599C (no) Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater
NO138061C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive substituerte difenylpropionsyrederivater
NO140348C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk aktive 3-(amino-2-hydroksypropoksy)-isoindolin-1-on-forbindelser
NO141651C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aroyl-substituerte fenyleddiksyrederivater
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
NO139088C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO136840C (no) Analogifremgangsm}te til fremstilling av nye, terapeutisk aktive derivater av isoindolin